Tower Research Capital (TRC)’s Iterum Therapeutics ITRM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-710
| Closed | -$1.26K | – | 5494 |
|
2024
Q4 | $1.26K | Buy |
+710
| New | +$1.26K | ﹤0.01% | 5058 |
|
2024
Q3 | – | Sell |
-100
| Closed | -$114 | – | 5847 |
|
2024
Q2 | $114 | Sell |
100
-368
| -79% | -$420 | ﹤0.01% | 5475 |
|
2024
Q1 | $721 | Buy |
+468
| New | +$721 | ﹤0.01% | 5396 |
|
2023
Q4 | – | Sell |
-22
| Closed | -$18 | – | 6050 |
|
2023
Q3 | $18 | Sell |
22
-10
| -31% | -$8 | ﹤0.01% | 5838 |
|
2023
Q2 | $34 | Sell |
32
-9,636
| -100% | -$10.2K | ﹤0.01% | 5867 |
|
2023
Q1 | $10K | Buy |
9,668
+5,267
| +120% | +$5.45K | ﹤0.01% | 4359 |
|
2022
Q4 | $4K | Buy |
4,401
+3,079
| +233% | +$2.8K | ﹤0.01% | 5022 |
|
2022
Q3 | $2K | Buy |
+1,322
| New | +$2K | ﹤0.01% | 5569 |
|
2022
Q1 | – | Sell |
-1,811
| Closed | -$11K | – | 6317 |
|
2021
Q4 | $11K | Buy |
+1,811
| New | +$11K | ﹤0.01% | 4422 |
|
2021
Q3 | – | Sell |
-7,759
| Closed | -$269K | – | 5954 |
|
2021
Q2 | $269K | Buy |
7,759
+7,753
| +129,217% | +$269K | 0.01% | 1693 |
|
2021
Q1 | $0 | Buy |
+6
| New | – | ﹤0.01% | 5545 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 3930 |
|
2019
Q3 | – | Sell |
-65
| Closed | -$7K | – | 4302 |
|
2019
Q2 | $7K | Buy |
65
+7
| +12% | +$754 | ﹤0.01% | 2766 |
|
2019
Q1 | $7K | Buy |
58
+10
| +21% | +$1.21K | ﹤0.01% | 2872 |
|
2018
Q4 | $4K | Sell |
48
-161
| -77% | -$13.4K | ﹤0.01% | 3041 |
|
2018
Q3 | $21K | Buy |
209
+204
| +4,080% | +$20.5K | ﹤0.01% | 2315 |
|
2018
Q2 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 3488 |
|